Programmed death-1–induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection
Top Cited Papers
- 7 March 2010
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 16 (4) , 452-459
- https://doi.org/10.1038/nm.2106
Abstract
Programmed death-1 (PD-1) and interleukin-10 (IL-10) impair T cell function during chronic viral infections. Microbial products are now found to inhibit T cell function during HIV infection by upregulating PD-1 and IL-10 production by monocytes. Viral replication and microbial translocation from the gut to the blood during HIV infection lead to hyperimmune activation, which contributes to the decline in CD4+ T cell numbers during HIV infection. Programmed death-1 (PD-1) and interleukin-10 (IL-10) are both upregulated during HIV infection. Blocking interactions between PD-1 and programmed death ligand-1 (PD-L1) and between IL-10 and IL-10 receptor (IL-10R) results in viral clearance and improves T cell function in animal models of chronic viral infections. Here we show that high amounts of microbial products and inflammatory cytokines in the plasma of HIV-infected subjects lead to upregulation of PD-1 expression on monocytes that correlates with high plasma concentrations of IL-10. Triggering of PD-1 expressed on monocytes by PD-L1 expressed on various cell types induced IL-10 production and led to reversible CD4+ T cell dysfunction. We describe a new function for PD-1 whereby microbial products inhibit T cell expansion and function by upregulating PD-1 levels and IL-10 production by monocytes after binding of PD-1 by PD-L1.This publication has 55 references indexed in Scilit:
- PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsisProceedings of the National Academy of Sciences, 2009
- IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotypeProceedings of the National Academy of Sciences, 2008
- Enhancing SIV-specific immunity in vivo by PD-1 blockadeNature, 2008
- PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: Restricted expression of type I interferon receptor by CCR5-expressing leukocytesClinical Immunology, 2008
- The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptorsProceedings of the National Academy of Sciences, 2008
- TLR-mediated induction of negative regulatory ligands on dendritic cellsJournal of Molecular Medicine, 2008
- Microbial translocation is a cause of systemic immune activation in chronic HIV infectionNature Medicine, 2006
- Interleukin-10 determines viral clearance or persistence in vivoNature Medicine, 2006
- Resolution of a chronic viral infection after interleukin-10 receptor blockadeThe Journal of Experimental Medicine, 2006
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005